Gamida Cell Ltd. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Commercial activities
Operating loss
Financial expenses
Financial income
Loss before taxes on income (tax benefit)
Taxes on income (tax benefit)
Net revenue
Cost of sales
Excess Capacity
Research and development expenses, net
Commercial expenses
General and administrative expenses
Selling, general and administrative
Other operating expenses
Total operating expenses
Total operating loss
Financial (income) expenses
Loss
Actuarial net gain (loss) of defined benefit plans
Changes in the fair value of marketable securities
Total comprehensive loss
Basic net loss per share (in Dollars per share)
Diluted net loss per share (in Dollars per share)
Net loss per share attributable to ordinary shareholders, basic and diluted (in Dollars per share)
Weighted average number of shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted (in Shares)
Net loss
Net loss per share attributable to ordinary shareholders, basic and diluted (in Dollars per share)
Net loss per share attributable to ordinary shareholders, basic (in Dollars per share)
Weighted average number of shares used in computing net loss per share attributable to ordinary shareholders, basic (in Shares)

Comments